These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7528089)

  • 1. Twisted alpha-keto amides as transition-state analogues for acyl-transfer reactions: synthesis of the immunoconjugates.
    Yli-Kauhaluoma J; Janda KD
    Bioorg Med Chem; 1994 Jun; 2(6):521-8. PubMed ID: 7528089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies for the design of catalytic antibodies.
    Janda KD
    Biotechnol Prog; 1990; 6(3):178-81. PubMed ID: 1366610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
    Krishnan R; Tulinsky A; Vlasuk GP; Pearson D; Vallar P; Bergum P; Brunck TK; Ripka WC
    Protein Sci; 1996 Mar; 5(3):422-33. PubMed ID: 8868478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical modification of rapamycin: the discovery of SDZ RAD.
    Sedrani R; Cottens S; Kallen J; Schuler W
    Transplant Proc; 1998 Aug; 30(5):2192-4. PubMed ID: 9723437
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonconventional amide bond formation catalysis: programming enzyme specificity with substrate mimetics.
    Bordusa F
    Braz J Med Biol Res; 2000 May; 33(5):469-85. PubMed ID: 10775878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised NMR assignments for rapamycin.
    McAlpine JB; Swanson SJ; Jackson M; Whittern DN
    J Antibiot (Tokyo); 1991 Jun; 44(6):688-90. PubMed ID: 1712766
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure and Reactivity of Highly Twisted N-Acylimidazoles.
    Stone EA; Mercado BQ; Miller SJ
    Org Lett; 2019 Apr; 21(7):2346-2351. PubMed ID: 30860852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in the fundamentals and therapeutic use of immunosuppressive agents].
    Ochiai T
    Arerugi; 1992 Mar; 41(3):381-4. PubMed ID: 1374229
    [No Abstract]   [Full Text] [Related]  

  • 10. Expanded transition state analogues.
    Blackburn GM; Kingsbury G; Jayaweera S; Burton DR
    Ciba Found Symp; 1991; 159():211-22; discussion 222-6. PubMed ID: 1959449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA screening of monoclonal antibodies to haptens: influence of the chemical structure of hapten-protein conjugates.
    Danilova NP
    J Immunol Methods; 1994 Jul; 173(1):111-7. PubMed ID: 8034978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrazole analogues of cyclolinopeptide A: synthesis, conformation, and biology.
    Kaczmarek K; Jankowski S; Siemion IZ; Wieczorek Z; Benedetti E; Di Lello P; Isernia C; Saviano M; Zabrocki J
    Biopolymers; 2002 May; 63(6):343-57. PubMed ID: 11920436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Characterization of Site-Selective Orbitide-BSA Conjugate to Produce Antibodies.
    Jadhav PD; Shim YY; Reaney MJ
    Bioconjug Chem; 2016 Oct; 27(10):2346-2358. PubMed ID: 27626291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing immunosuppressant action with a nonnatural immunophilin ligand.
    Bierer BE; Somers PK; Wandless TJ; Burakoff SJ; Schreiber SL
    Science; 1990 Oct; 250(4980):556-9. PubMed ID: 1700475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening strategies for catalytic antitransition-state analog antibodies.
    Tramontano A
    Methods Mol Biol; 1995; 51():237-50. PubMed ID: 7581701
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism for the rotamase activity of FK506 binding protein from molecular dynamics simulations.
    Orozco M; Tirado-Rives J; Jorgensen WL
    Biochemistry; 1993 Nov; 32(47):12864-74. PubMed ID: 8251509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cis amide bond surrogate incorporating 1,2,4-triazole.
    Hitotsuyanagi Y; Motegi S; Fukaya H; Takeya K
    J Org Chem; 2002 May; 67(10):3266-71. PubMed ID: 12003534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.
    Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement.
    Baker WR; Fung AK; Kleinert HD; Stein HH; Plattner JJ; Armiger YL; Condon SL; Cohen J; Egan DA; Barlow JL
    J Med Chem; 1992 May; 35(10):1722-34. PubMed ID: 1588554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water-promoted hydrolysis of a highly twisted amide: rate acceleration caused by the twist of the amide bond.
    Mujika JI; Mercero JM; Lopez X
    J Am Chem Soc; 2005 Mar; 127(12):4445-53. PubMed ID: 15783227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.